Lobotomies were never banned by a single sweeping international law. Instead, they were abandoned through a slow, grinding convergence of devastating clinical outcomes, ethical revulsion, the arrival of effective psychiatric medications, and, in some countries, explicit government action. The procedure left the vast majority of patients with permanent personality damage, and the story of how medicine moved away from it is as much about institutional failures and power politics as it is about science correcting itself.
What Lobotomies Did and Why Doctors Performed Them
The first prefrontal lobotomy on a human was performed in 1935 by Portuguese neurologist António Egas Moniz, who, after learning about experiments on chimpanzees at a neurology conference in London, theorized that severing the nerve fibers connecting the frontal lobes to the thalamus could cure mental illness. Working with his surgical colleague Almeida Lima, Moniz used a specialized instrument called a leucotome to inject alcohol into the white matter and mechanically cut nerve pathways.1Europe PMC. António Egas Moniz (1874-1955): Lobotomy pioneer and Nobel laureate The procedure spread rapidly across Europe and North America during the 1940s and 1950s, driven by overcrowded psychiatric institutions, a lack of any other treatment for severe mental illness, and a medical establishment eager for solutions.
The most aggressive adopter was American neurologist Walter Freeman, who developed the “ice pick” transorbital lobotomy, a technique he could perform in minutes through the eye socket without a proper operating room. Freeman traveled the country performing the procedure, sometimes on dozens of patients in a single day. The speed and simplicity of his method made lobotomy accessible far beyond specialized surgical centers, which meant it was also performed in settings with minimal oversight, on patients who often had no meaningful say in the matter.
At the heart of the procedure’s appeal was a brutal logic: patients who had been violent, agitated, or unmanageable in institutions often became docile afterward. Hospitals saw lobotomy as a way to reduce the burden of caring for severely ill patients. In the Soviet Union, psychiatrists explicitly justified it as a “last resort” that helped make patients more manageable and allowed some to return to work.2PubMed. Banning the Soviet Lobotomy: Psychiatry, Ethics, and Professional Politics during Late Stalinism Manageability, though, is a very different thing from recovery, and that distinction would eventually become impossible to ignore.
The Damage That Emerged Over Time
Early reports on lobotomy outcomes were cautiously optimistic, partly because success was defined narrowly. If a patient stopped being violent or could leave the hospital, the procedure was counted as an improvement. But follow-up studies revealed a much darker picture. In one study that tracked over a hundred lobotomy patients for roughly a decade after surgery, about two-thirds improved enough to live outside a hospital, but a full 91 percent were left with a measurable personality defect. Twelve percent developed epilepsy as a direct complication of the surgery, and over a quarter of those who initially improved relapsed and needed further treatment.3PubMed Central. The lobotomy patient–a decade later: a follow-up study of a research project started in 1948
That 91 percent figure is staggering. The “personality defect” label covered a wide range of damage: blunted emotions, apathy, inability to plan or make decisions, loss of initiative, social inappropriateness, and a flattened inner life. People who had been anxious or agitated before the surgery often became placid, but in a way that their families described as losing the person they knew. The frontal lobes are central to what makes someone recognizably themselves, and destroying tissue there, without precision and without understanding which circuits did what, was essentially trading one catastrophe for another.
A separate long-term study examined schizophrenic patients roughly 25 years after prefrontal leukotomy, using neurological exams, brain scans, and neuropsychological testing. The results were paradoxical in a way that underscored how crude the original procedures were: patients with larger frontal lesions, especially asymmetric ones, actually performed better psychiatrically and on cognitive tests, but there was no correlation between lesion size and neurological or brain-wave abnormalities.4PubMed. The long-term effects of prefrontal leukotomy In other words, the outcomes were essentially random. Surgeons had no reliable way to predict who would benefit and who would be devastated, because they were working without any real understanding of the brain’s functional architecture.
Why the Harms Were Tolerated for So Long
The persistence of lobotomy through the 1940s and into the 1950s, despite growing evidence of harm, is one of the more uncomfortable chapters in medical history. Several factors kept the procedure going. Psychiatric hospitals were massively overcrowded; at their peak, American state hospitals held over half a million patients. There were no effective drugs for psychosis, severe depression, or debilitating anxiety. Families were desperate, and doctors had essentially nothing else to offer.
Media coverage played a complicated role. Press reporting on lobotomy was initially uncritical and sensational, presenting the procedure as a miracle breakthrough. Analysis of press coverage from 1935 through 1960 shows that articles became increasingly negative over time, but the early wave of enthusiastic reporting likely accelerated lobotomy’s adoption.5PubMed. Portrayal of lobotomy in the popular press: 1935-1960 By the time journalists began questioning the procedure seriously, tens of thousands of lobotomies had already been performed.
There was also institutional inertia. Moniz received the Nobel Prize in Physiology or Medicine in 1949 for developing the procedure, which lent it enormous prestige at exactly the moment when doubts should have been growing. The Nobel committee’s endorsement made it harder for skeptics within the medical profession to push back. It remains one of the most controversial Nobel Prizes ever awarded.
Chlorpromazine and the End of the Lobotomy Era
The single biggest factor in the decline of lobotomy was pharmacological, not ethical. Chlorpromazine, the first true antipsychotic medication, was synthesized in late 1951 and became available by prescription in France in November 1952. Its effect on psychiatric wards was dramatic and immediate: patients who had been severely agitated became calm enough to hold conversations, participate in their own care, and in some cases leave the hospital.6Europe PMC. Fifty years chlorpromazine: a historical perspective The drug’s commercial success also spurred the development of other psychotropic medications through the 1950s and 1960s, rapidly expanding the toolkit available to psychiatrists.
Chlorpromazine did not cure schizophrenia or other severe mental illnesses. It had serious side effects of its own, including movement disorders that could become permanent. But it offered something lobotomy never could: reversibility. If a medication made a patient worse, a doctor could stop it. A lobotomy could not be undone. That fundamental difference made the ethical calculus of the two approaches incomparable, and once effective drugs existed, the argument that lobotomy was a justified “last resort” collapsed almost overnight.
The timing mattered. Lobotomy rates in the United States peaked in the late 1940s and began falling sharply after chlorpromazine became widely available in the mid-1950s. By the 1960s, the procedure had become rare in most Western countries, though it continued sporadically in some places into the 1970s and beyond.
The Ethics That Were Violated
Informed consent, as we understand it today, barely existed when lobotomies were at their peak. Patients in psychiatric institutions often had no legal standing to refuse treatment. Many lobotomies were performed on people who were incapable of understanding what was being proposed, or who explicitly objected but were overruled by family members or hospital administrators. Children, prisoners, and people committed involuntarily were among those operated on.
The ethical problems went deeper than consent. Lobotomy was disproportionately performed on women and on people whose behavior was considered socially unacceptable rather than medically dangerous. The line between “treating mental illness” and “enforcing conformity” was often impossible to draw. In the Soviet Union, the political dimension became explicit: between 1947 and 1949, debates among psychiatrists about lobotomy’s validity became entangled with Communist Party ideological campaigns, and by 1950, the procedure was banned partly as a rejection of what was framed as a harmful Western influence.2PubMed. Banning the Soviet Lobotomy: Psychiatry, Ethics, and Professional Politics during Late Stalinism The Soviet ban was motivated by politics as much as by genuine concern for patients, but the ethical critiques Soviet psychiatrists raised, particularly that lobotomy caused injuries more significant than the behavioral changes it produced, were entirely valid.
In mid-twentieth-century psychiatry, lobotomy was one of a trio of aggressive physical interventions, alongside insulin coma therapy and electroshock, that were performed routinely on people who were often unwitting or unwilling.7Ethical Human Psychology and Psychiatry. Electroshock: On How and Why It Lingers on Long After Insulin Coma Shock and Lobotomy Are Gone Of the three, lobotomy and insulin coma therapy were eventually abandoned entirely. The fact that these procedures were performed at scale on vulnerable people, with minimal evidence of benefit and substantial evidence of harm, helped catalyze the modern framework of research ethics and patient protections.
Government Responses and Formal Restrictions
The regulatory aftermath of the lobotomy era varied significantly by country. The Soviet Union’s ban in 1950 was the earliest outright prohibition, though as noted, it was as much about political maneuvering as patient welfare. In the United States, the federal government never formally banned lobotomy. Instead, in 1977, the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research issued a report on psychosurgery that recommended strict safeguards, including independent review of each case and rigorous informed consent requirements. These recommendations effectively made the procedure nearly impossible to perform outside of carefully controlled research settings, but they stopped short of an outright ban.
Norway took one of the most explicit steps toward accountability. The Norwegian government agreed to pay compensation of 200,000 kroner (roughly £20,000 at the time) to each of an estimated 500 surviving patients who had undergone prefrontal lobotomy between 1941 and 1974. A total of about 2,500 patients had been subjected to the procedure in Norway, and the health minister publicly acknowledged that the state bore a “heavy responsibility” for the operations.8BMJ. Norway compensates lobotomy victims Norway’s compensation program remains one of the few cases where a government formally acknowledged the harm lobotomy caused and made financial restitution.
Most countries followed a pattern closer to the American model: lobotomy was not explicitly outlawed but was gradually regulated into near-extinction through ethics requirements, institutional review processes, and the practical reality that effective medications had made it unnecessary. A handful of countries, including Japan, continued performing lobotomies into the 1970s under loose regulation before public pressure and professional consensus finally ended the practice.
How Fiction Shaped Public Opinion
Cultural portrayals played a surprisingly large role in turning the public against lobotomy. Novels, plays, and films featuring lobotomized characters contributed to a growing sense of horror about the procedure. The most famous example is Ken Kesey’s 1962 novel One Flew Over the Cuckoo’s Nest and its 1975 film adaptation, which depicted lobotomy as the ultimate tool of institutional control. But the phenomenon was broader: ominous portrayals of lobotomized patients in fiction steadily diminished public opinion of both the procedure and the medical professionals who performed it.9Journal of Neurosurgery. Psychosurgery, ethics, and media: a history of Walter Freeman and the lobotomy
These fictional depictions were often melodramatic, but they were not fundamentally dishonest. The reality of lobotomy, in which patients emerged with flattened personalities and diminished agency, was genuinely disturbing, and fiction simply made visible what clinical follow-up studies were documenting in drier language. The cultural stigmatization of psychosurgery extended beyond lobotomy itself and made it much harder for any brain surgery aimed at treating psychiatric conditions to gain public acceptance, a dynamic that persists today.
Modern Psychosurgery and the Lobotomy’s Long Shadow
Lobotomy is gone, but brain surgery for psychiatric conditions is not entirely extinct. Modern procedures bear almost no resemblance to the crude tissue destruction of the lobotomy era. Techniques like bilateral anterior cingulotomy, developed using MRI-guided stereotactic methods, target tiny, precisely defined brain areas and are reserved for patients with severe, treatment-resistant obsessive-compulsive disorder or major depression who have exhausted all other options.10PubMed Central. The Evolution of Modern Ablative Surgery for the Treatment of Obsessive-Compulsive and Major Depression Disorders The differences from lobotomy are substantial: the lesions are millimeters in size rather than spanning entire lobes, the targets are chosen based on decades of neuroimaging research, patients undergo extensive screening and provide genuine informed consent, and independent ethics boards review every case.
Deep brain stimulation, which uses implanted electrodes to modulate brain circuits without destroying tissue, is another technology that has been explored for treatment-resistant depression and OCD. Unlike ablative surgery, DBS is reversible: the device can be turned off or adjusted. Yet even DBS proposals generate ethical scrutiny rooted directly in the lobotomy’s legacy. Researchers have argued, for instance, that proposed uses of DBS for conditions like obesity echo the lobotomy era’s pattern of pathologizing nonconformity under the guise of therapeutic innovation.11PubMed Central. Why Deep Brain Stimulation for Obesity Is Ethically Impermissible The memory of lobotomy functions as a kind of ethical immune system for neuroscience: any proposal to alter brain function surgically faces an automatic, heightened level of skepticism that would not exist without the historical precedent.
Who Received Lobotomies and Why That Matters
The demographics of lobotomy patients tell a story about who medicine was willing to experiment on. Women received lobotomies at significantly higher rates than men. Institutionalized patients, who were disproportionately poor and marginalized, were prime candidates precisely because they were least able to refuse. Walter Freeman performed lobotomies on patients as young as four years old. In many cases, the “symptoms” being treated, such as emotional outbursts, disobedience, or sexual behavior deemed inappropriate, were not illnesses in any meaningful sense but deviations from social expectations.
This dimension of the lobotomy story connects to broader questions about psychiatric power that are still relevant. When a treatment’s primary effect is making someone easier to manage rather than reducing their suffering, the question of whose interests are being served becomes unavoidable. The lobotomy era forced that question into the open, and the answers were uncomfortable enough to reshape how medical ethics approaches psychiatric treatment. The requirement for truly informed consent, the principle that irreversible procedures demand extraordinary justification, and the insistence that treatment should serve the patient’s interests rather than institutional convenience all trace their modern urgency, at least in part, to the lobotomy’s legacy.
Why Lobotomy Was Not Simply “Bad Science”
It would be reassuring to frame lobotomy as a product of ignorance, as something that happened because doctors simply did not know better. The reality is messier. The medical profession had access to evidence of harm throughout the procedure’s peak years. Follow-up data showing devastating personality changes were published and discussed at conferences. Individual doctors, including some within the Soviet psychiatric establishment, raised ethical objections early on. The problem was not a lack of information but a failure of institutions, professional incentives, and moral imagination.
Doctors who performed lobotomies were operating within a medical culture that prioritized action over caution, that defined success in terms of institutional convenience rather than patient wellbeing, and that gave physicians enormous unchecked power over vulnerable people. The Nobel Prize for the procedure’s inventor reflected and reinforced that culture. Understanding the lobotomy era as primarily a failure of ethics and institutions, rather than of knowledge alone, is what makes it useful as a cautionary tale. The science of the brain has advanced enormously since the 1940s, but the institutional pressures that enabled lobotomy, specifically overcrowded systems, underfunded alternatives, vulnerable patients with limited power, and clinicians under pressure to do something, have not disappeared.